TGFB1 and myocardial infarction: Empagliflozin treatment attenuated oxidative stress [72], and dapagliflozin treatment lowered cardiac transcripts of inflammatory cytokines (TNFα, TGF-β1, Vcam-1, MCP-1, Icam-1, IL-6) [77] in mouse/rat MI models.